Tag:
PRT-201
Latest Headlines
Latest Headlines
Proteon Therapeutics boosts Series B to $50M
Waltham, MA-based Proteon Therapeutics has rounded up $12 million in a second close of its second round, raising its take in the Series B to an even $50 million. Two new investors, Bessemer Venture
Novartis options Proteon Therapeutics for $550M
Proteon Therapeutics has more than $550 million riding on its mid-stage trial of its blood-vessel dilating therapy. That's how much Novartis has agreed to pay for the company--in an upfront payment
